0

Infectious Disease Diagnostics Market by End-user and Geography - Forecast and Analysis 2022-2026

  • Published: Jun 2022
  • Pages: 123
  • SKU: IRTNTR73777
Technavio

Enjoy complimentary customisation on priority with our Enterprise License!

Safe and Secure SSL Encrypted

info
close
  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization)
    Complimentary Customization Included

2500 USD

The infectious disease diagnostics market share is expected to increase to USD 13.94 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 6.7%.

This infectious disease diagnostics market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers infectious disease diagnostics market segmentation by end-user (hospitals and labs) and geography (North America, Europe, Asia, and Rest of World (ROW)). The infectious disease diagnostics market report also offers information on several market vendors, including Abbott Laboratories, Becton Dickinson and Co., Bio Rad Laboratories Inc., bioMerieux SA, Danaher Corp., DiaSorin SpA, F. Hoffmann La Roche Ltd., Genetic Signatures Ltd., Grifols SA, Hologic Inc., Meridian Bioscience Inc., Meril Life Sciences Pvt. Ltd., OraSure Technologies Inc., PerkinElmer Inc., QIAGEN NV, Siemens AG, Sysmex Corp., Thermo Fisher Scientific Inc., Trinity Biotech Plc, and Vela Diagnostics among others.

What will the Infectious Disease Diagnostics Market Size be During the Forecast Period?

Infectious Disease Diagnostics Market Size

Download the Free Report Sample to Unlock the Infectious Disease Diagnostics Market Size for the Forecast Period and Other Important Statistics

 

Infectious Disease Diagnostics Market: Key Drivers, Trends, and Challenges

The increasing prevalence of infectious diseases is notably driving the infectious disease diagnostics market growth, although factors such as the availability of counterfeit drugs in the developing economies may impede market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the infectious disease diagnostics industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Infectious Disease Diagnostics Market Driver

  • One of the key factors driving the global infectious disease diagnostics market growth is the increasing prevalence of infectious diseases.
  • The outbreaks of infectious diseases have increased due to changing lifestyles, which result in reduced immunity.
  • The pattern of infection incidence has also been changing with the evolution of drug-resistant pathogens.
  • As per the Joint United Nations Programme on HIV/AIDS data of 2020, 680,000 people died from AIDS-related illnesses across the world.
  • The prevalence of meningococcal disease, which is caused by the bacterium Neisseria, meningitides, was decreased, owing to the meningococcal vaccines, which were licensed and made available in August 2020 in the US.
  • According to the CDC data for 2021, annually, almost 4,100 cases and 500 deaths occur due to meningococcal disease in the US.
  • The rise in the prevalence of infectious diseases is expected to drive the growth of the market in focus during the forecast period.

Key Infectious Disease Diagnostics Market Trend

  • Increase in M&A is one of the key infectious disease diagnostics market trends that is expected to impact the industry positively in the forecast period.
  • The vendors operating in the market are focusing on pursuing inorganic growth to tap into rapidly growing markets, such as India, Brazil, China, and South Africa.
  • In August 2021, Sanofi S.A acquired Translate Bio Inc., a clinical-stage mRNA therapeutics company, for over $3 billion.
  • In April 2021, Pfizer Inc. acquired Amplyx Pharmaceuticals Inc., an American pharmaceutical company, with an aim to access the Fosmanogepix (APX001).
  • In May 2020, Novavax Inc., a biotechnology company specializing in next-generation vaccines, spent over $160 million and acquired Praha Vaccines A.S.
  • A rise in M&A activities across the globe is anticipated to boost the growth of the market in the forecast years.

Key Infectious Disease Diagnostics Market Challenge

  • One of the key challenges to the global infectious disease diagnostics market growth is the availability of counterfeit drugs in developing economies.
  • The counterfeit products pose a challenge for the global pharmaceutical manufacturers, costing them billions of dollars and negatively affecting their brand reputation.
  • Counterfeit drugs provide a false sense of security to the patients using them while endangering them even more with the contents of the products.
  • The counterfeits are widely available in low-income and developing countries because of insufficient regulations and manufacturing control.
  • The fear of stigma often makes HIV patients buy antiretrovirals through unauthorized retailers.
  • Due to the increase in the prevalence of AIDS in underdeveloped countries, such as India, Brazil, and Iran, counterfeiters may gain profits from the counterfeiting of antiretroviral drugs without easily being noticed.
  • The wide availability of counterfeit drugs may hamper the growth of the market in focus during the forecast period.

This infectious disease diagnostics market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.

Parent Market Analysis

Technavio categorizes the global infectious disease diagnostics market as a part of the global healthcare equipment market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the infectious disease diagnostics market during the forecast period.

Who are the Major Infectious Disease Diagnostics Market Vendors?

The report analyzes the market's competitive landscape and offers information on several market vendors, including:

 

  • Abbott Laboratories
  • Becton Dickinson and Co.
  • Bio Rad Laboratories Inc.
  • bioMerieux SA
  • Danaher Corp.
  • DiaSorin SpA
  • F. Hoffmann La Roche Ltd.
  • Genetic Signatures Ltd.
  • Grifols SA
  • Hologic Inc.
  • Meridian Bioscience Inc.
  • Meril Life Sciences Pvt. Ltd.
  • OraSure Technologies Inc.
  • PerkinElmer Inc.
  • QIAGEN NV
  • Siemens AG
  • Sysmex Corp.
  • Thermo Fisher Scientific Inc.
  • Trinity Biotech Plc
  • Vela Diagnostics

 

This statistical study of the infectious disease diagnostics market encompasses successful business strategies deployed by the key vendors. The infectious disease diagnostics market is fragmented and the vendors are deploying growth strategies such as investment in research and development to compete in the market.

Product Insights and News

  • Abbott Laboratories - Under the established pharmaceuticals products segment, the company focuses on core laboratory, molecular solutions, point of care solutions, and rapid diagnostics.
  • Becton Dickinson and Co. - The BD Medical segment offers a range of medication delivery solutions, medication management solutions, diabetes care, and pharmaceutical systems.

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The infectious disease diagnostics market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Infectious Disease Diagnostics Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the infectious disease diagnostics market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

Which are the Key Regions for Infectious Disease Diagnostics Market?

Infectious Disease Diagnostics Market Market segmentation by region

For more insights on the market share of various regions Request for a FREE sample now!

37% of the market's growth will originate from North America during the forecast period. US and Canada are the key markets for infectious disease diagnostics in North America. Market growth in this region will be faster than the growth of the market in Europe and ROW.

The increase in the prevalence of infectious diseases, such as AIDS, TB, meningitis, influenza, and pneumonia will facilitate the infectious disease diagnostics market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

In 2020, the outbreak of COVID-19 affected the economies of all countries in North America, especially the US. However, the pandemic had a mixed impact on the regional infectious disease diagnostics market. The rise in the number of COVID-19 cases in the first quarter of 2020 led to partial lockdowns in several countries, including Canada and Mexico. Most of the pharmaceutical operations were directed toward developing vaccines and therapeutics for COVID-19, which fostered the growth of the regional infectious disease diagnostics market in 2020 and mid-2021 to a substantial extent. For instance, in December 2020, the US FDA authorized the COVID-19 mRNA vaccine, developed by Pfizer Inc. and BioNTech SE, for emergency use in the US. Thus, the rising prevalence of infectious diseases in the region will drive the growth of the regional infectious disease diagnostics market during the forecast period.

What are the Revenue-generating End-user Segments in the Infectious Disease Diagnostics Market?

Infectious Disease Diagnostics Market Segmentation

To gain further insights on the market contribution of various segments Request for a FREE sample

The infectious disease diagnostics market share growth by the hospital segment will be significant during the forecast period. The growth is attributed to the increase in the number of patients suffering from different types of diseases, such as AIDS, tuberculosis (TB) meningitis, and COVID-19, globally. The growing presence of the large-, medium-, and small-sized hospitals that procure medical products, including infectious disease diagnostic instruments, in bulk from suppliers and group purchasing organizations (GPOs) will further boost the market growth. 

This report provides an accurate prediction of the contribution of all the segments to the growth of the infectious disease diagnostics market size and actionable market insights on post COVID-19 impact on each segment.

 

Infectious Disease Diagnostics Market Scope

Report Coverage

Details

Page number

120

Base year

2021

Forecast period

2022-2026

Growth momentum & CAGR

Accelerate at a CAGR of 6.7%

Market growth 2022-2026

$ 13.94 billion

Market structure

Fragmented

YoY growth (%)

5.11

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 37%

Key consumer countries

US, Canada, Germany, UK, and China

Competitive landscape

Leading companies, Competitive strategies, Consumer engagement scope

Key companies profiled

Abbott Laboratories, Becton Dickinson and Co., Bio Rad Laboratories Inc., bioMerieux SA, Danaher Corp., DiaSorin SpA, F. Hoffmann La Roche Ltd., Genetic Signatures Ltd., Grifols SA, Hologic Inc., Meridian Bioscience Inc., Meril Life Sciences Pvt. Ltd., OraSure Technologies Inc., PerkinElmer Inc., QIAGEN NV, Siemens AG, Sysmex Corp., Thermo Fisher Scientific Inc., Trinity Biotech Plc, and Vela Diagnostics

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request for a FREE sample

What are the Key Data Covered in this Infectious Disease Diagnostics Market Report?

  • CAGR of the market during the forecast period 2022-2026
  • Detailed information on factors that will drive infectious disease diagnostics market growth during the next five years
  • Precise estimation of the infectious disease diagnostics market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the infectious disease diagnostics industry across North America, Europe, Asia, and Rest of World (ROW)
  • A thorough analysis of the market's competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of infectious disease diagnostics market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by End-user
    • Exhibit 06: Executive Summary – Chart on Incremental Growth
    • Exhibit 07: Executive Summary – Data Table on Incremental Growth
    • Exhibit 08: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 09: Parent market
    • Exhibit 10: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 11: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 12: Market segments
  • 3.3 Market size 2021
    • 3.4 Market outlook: Forecast for 2021-2026
      • Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
      • Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
      • Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
      • Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

    4 Five Forces Analysis

    • 4.1 Five forces summary
      • Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
    • 4.2 Bargaining power of buyers
      • Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
    • 4.3 Bargaining power of suppliers
      • Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
    • 4.4 Threat of new entrants
      • Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
    • 4.5 Threat of substitutes
      • Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
    • 4.6 Threat of rivalry
      • Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
    • 4.7 Market condition
      • Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

    5 Market Segmentation by End-user

    • 5.1 Market segments
      • Exhibit 24: Chart on End-user - Market share 2021-2026 (%)
      • Exhibit 25: Data Table on End-user - Market share 2021-2026 (%)
    • 5.2 Comparison by End-user
      • Exhibit 26: Chart on Comparison by End-user
      • Exhibit 27: Data Table on Comparison by End-user
    • 5.3 Hospitals - Market size and forecast 2021-2026
      • Exhibit 28: Chart on Hospitals - Market size and forecast 2021-2026 ($ million)
      • Exhibit 29: Data Table on Hospitals - Market size and forecast 2021-2026 ($ million)
      • Exhibit 30: Chart on Hospitals - Year-over-year growth 2021-2026 (%)
      • Exhibit 31: Data Table on Hospitals - Year-over-year growth 2021-2026 (%)
    • 5.4 Labs - Market size and forecast 2021-2026
      • Exhibit 32: Chart on Labs - Market size and forecast 2021-2026 ($ million)
      • Exhibit 33: Data Table on Labs - Market size and forecast 2021-2026 ($ million)
      • Exhibit 34: Chart on Labs - Year-over-year growth 2021-2026 (%)
      • Exhibit 35: Data Table on Labs - Year-over-year growth 2021-2026 (%)
    • 5.5 Market opportunity by End-user
      • Exhibit 36: Market opportunity by End-user ($ million)

    6 Customer Landscape

    • 6.1 Customer landscape overview
      • Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    7 Geographic Landscape

    • 7.1 Geographic segmentation
      • Exhibit 38: Chart on Market share by geography 2021-2026 (%)
      • Exhibit 39: Data Table on Market share by geography 2021-2026 (%)
    • 7.2 Geographic comparison
      • Exhibit 40: Chart on Geographic comparison
      • Exhibit 41: Data Table on Geographic comparison
    • 7.3 North America - Market size and forecast 2021-2026
      • Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
      • Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
      • Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
      • Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
    • 7.4 Europe - Market size and forecast 2021-2026
      • Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
      • Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
      • Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
      • Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
    • 7.5 Asia - Market size and forecast 2021-2026
      • Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
      • Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
      • Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
      • Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
    • 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
      • Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
      • Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
      • Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
      • Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
    • 7.7 US - Market size and forecast 2021-2026
      • Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
      • Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
      • Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
      • Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
    • 7.8 Germany - Market size and forecast 2021-2026
      • Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
      • Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
      • Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
      • Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
    • 7.9 China - Market size and forecast 2021-2026
      • Exhibit 66: Chart on China - Market size and forecast 2021-2026 ($ million)
      • Exhibit 67: Data Table on China - Market size and forecast 2021-2026 ($ million)
      • Exhibit 68: Chart on China - Year-over-year growth 2021-2026 (%)
      • Exhibit 69: Data Table on China - Year-over-year growth 2021-2026 (%)
    • 7.10 UK - Market size and forecast 2021-2026
      • Exhibit 70: Chart on UK - Market size and forecast 2021-2026 ($ million)
      • Exhibit 71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
      • Exhibit 72: Chart on UK - Year-over-year growth 2021-2026 (%)
      • Exhibit 73: Data Table on UK - Year-over-year growth 2021-2026 (%)
    • 7.11 Canada - Market size and forecast 2021-2026
      • Exhibit 74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
      • Exhibit 75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
      • Exhibit 76: Chart on Canada - Year-over-year growth 2021-2026 (%)
      • Exhibit 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
    • 7.12 Market opportunity by geography
      • Exhibit 78: Market opportunity by geography ($ million)

    8 Drivers, Challenges, and Trends

    • 8.1 Market drivers
      • 8.2 Market challenges
        • 8.3 Impact of drivers and challenges
          • Exhibit 79: Impact of drivers and challenges in 2021 and 2026
        • 8.4 Market trends

          9 Vendor Landscape

          • 9.1 Overview
            • 9.2 Vendor landscape
              • Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
            • 9.3 Landscape disruption
              • Exhibit 81: Overview on factors of disruption
            • 9.4 Industry risks
              • Exhibit 82: Impact of key risks on business

            10 Vendor Analysis

            • 10.1 Vendors covered
              • Exhibit 83: Vendors covered
            • 10.2 Market positioning of vendors
              • Exhibit 84: Matrix on vendor position and classification
            • 10.3 Abbott Laboratories
              • Exhibit 85: Abbott Laboratories - Overview
              • Exhibit 86: Abbott Laboratories - Business segments
              • Exhibit 87: Abbott Laboratories - Key news
              • Exhibit 88: Abbott Laboratories - Key offerings
              • Exhibit 89: Abbott Laboratories - Segment focus
            • 10.4 Becton Dickinson and Co.
              • Exhibit 90: Becton Dickinson and Co. - Overview
              • Exhibit 91: Becton Dickinson and Co. - Business segments
              • Exhibit 92: Becton Dickinson and Co. - Key news
              • Exhibit 93: Becton Dickinson and Co. - Key offerings
              • Exhibit 94: Becton Dickinson and Co. - Segment focus
            • 10.5 Bio Rad Laboratories Inc.
              • Exhibit 95: Bio Rad Laboratories Inc. - Overview
              • Exhibit 96: Bio Rad Laboratories Inc. - Business segments
              • Exhibit 97: Bio Rad Laboratories Inc. - Key news
              • Exhibit 98: Bio Rad Laboratories Inc. - Key offerings
              • Exhibit 99: Bio Rad Laboratories Inc. - Segment focus
            • 10.6 bioMerieux SA
              • Exhibit 100: bioMerieux SA - Overview
              • Exhibit 101: bioMerieux SA - Product / Service
              • Exhibit 102: bioMerieux SA - Key offerings
            • 10.7 DiaSorin SpA
              • Exhibit 103: DiaSorin SpA - Overview
              • Exhibit 104: DiaSorin SpA - Business segments
              • Exhibit 105: DiaSorin SpA - Key offerings
              • Exhibit 106: DiaSorin SpA - Segment focus
            • 10.8 F. Hoffmann La Roche Ltd.
              • Exhibit 107: F. Hoffmann La Roche Ltd. - Overview
              • Exhibit 108: F. Hoffmann La Roche Ltd. - Business segments
              • Exhibit 109: F. Hoffmann La Roche Ltd. - Key news
              • Exhibit 110: F. Hoffmann La Roche Ltd. - Key offerings
              • Exhibit 111: F. Hoffmann La Roche Ltd. - Segment focus
            • 10.9 Hologic Inc.
              • Exhibit 112: Hologic Inc. - Overview
              • Exhibit 113: Hologic Inc. - Business segments
              • Exhibit 114: Hologic Inc. - Key news
              • Exhibit 115: Hologic Inc. - Key offerings
              • Exhibit 116: Hologic Inc. - Segment focus
            • 10.10 QIAGEN NV
              • Exhibit 117: QIAGEN NV - Overview
              • Exhibit 118: QIAGEN NV - Product / Service
              • Exhibit 119: QIAGEN NV - Key news
              • Exhibit 120: QIAGEN NV - Key offerings
            • 10.11 Thermo Fisher Scientific Inc.
              • Exhibit 121: Thermo Fisher Scientific Inc. - Overview
              • Exhibit 122: Thermo Fisher Scientific Inc. - Business segments
              • Exhibit 123: Thermo Fisher Scientific Inc. - Key news
              • Exhibit 124: Thermo Fisher Scientific Inc. - Key offerings
              • Exhibit 125: Thermo Fisher Scientific Inc. - Segment focus
            • 10.12 Trinity Biotech Plc
              • Exhibit 126: Trinity Biotech Plc - Overview
              • Exhibit 127: Trinity Biotech Plc - Product / Service
              • Exhibit 128: Trinity Biotech Plc - Key offerings

            11 Appendix

            • 11.1 Scope of the report
              • 11.2 Inclusions and exclusions checklist
                • Exhibit 129: Inclusions checklist
                • Exhibit 130: Exclusions checklist
              • 11.3 Currency conversion rates for US$
                • Exhibit 131: Currency conversion rates for US$
              • 11.4 Research methodology
                • Exhibit 132: Research methodology
                • Exhibit 133: Validation techniques employed for market sizing
                • Exhibit 134: Information sources
              • 11.5 List of abbreviations
                • Exhibit 135: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              TechnavioINFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases
              Technavio

              TechnavioDATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts
              Technavio

              TechnavioREPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape
              Interested in this report?
              Get your sample now!
              Infectious Disease Diagnostics Market market growth will increase by $13.94 billion during 2022-2026.
              The infectious disease diagnostics market market is expected to grow at a CAGR of 6.7% during 2022-2026.
              Technavio has segmented the infectious disease diagnostics market market by end-user (Hospitals and Labs) and geography (North America, Europe, Asia, and Rest of World (ROW)).
              Abbott Laboratories, Becton Dickinson and Co., Bio Rad Laboratories Inc., bioMerieux SA, Danaher Corp., DiaSorin SpA, F. Hoffmann La Roche Ltd., Genetic Signatures Ltd., Grifols SA, Hologic Inc., Meridian Bioscience Inc., Meril Life Sciences Pvt. Ltd., OraSure Technologies Inc., PerkinElmer Inc., QIAGEN NV, Siemens AG, Sysmex Corp., Thermo Fisher Scientific Inc., Trinity Biotech Plc, Vela Diagnostics are a few of the key vendors in the infectious disease diagnostics market market.
              North America will register the highest growth rate of 37% among the other regions. Therefore, the infectious disease diagnostics market market in North America is expected to garner significant business opportunities for the vendors during the forecast period.
              The key factors driving the infectious disease diagnostics market market growth are:
              • Increasing prevalence of infectious diseases
              • Increase in M and A
              The infectious disease diagnostics market market vendors should focus on grabbing business opportunities from the hospitals segment as it accounted for the largest market share in the base year.
              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?
              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis

              Certified ISO 9001 : 2015

              We are ISO recognized

              We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.

              We are GDPR and CCPA compliant

              We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.

              Safe and Secure SSL Encrypted
              Technavio

              info
              close
              • Single:

                One user only.
                Quick & easy download option

              • Enterprise:

                Unlimited user access (Within your organization)
                Complimentary Customization Included

              2500 USD

              Technavio Get the report (PDF) sent to your email within minutes.

              Subscribe & Save

              Get lifetime access to our
              Technavio Insights

              Customized Report as per your Business Needs

              • Our analysts will work directly with you and understand your needs
              • Get data on specified regions or segments, competitor and Vendors
              • Data will be formatted and presented as per your requirements
              • We offer $1000 worth of FREE customization at the time of purchase

              Let us help you make report more suited to your requirements.

              • Get a competitive breakdown as per your niche industry
              • Customize the data with various metrics that meet your business prerequisite
              • Understand Revenue Sources, Customers and many more
              • Details on Market Share
              • These customizations are done in a short amount of time by our analysts and industry experts
              Technavio
              Enquire Before Buying
              17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>